A privately held biologics company in preclinical development stage company needed to build an investment case and package its data to attract VC funding.
The company’s CEO and executive Chairman engaged MSC in creating an investment package comprising a non-confidential pitch deck, a comprehensive confidential company presentation and a detailed investment memo. Visual high-quality presentations, reports, fact sheets and memorandums were created to meet the executives’ needs for key meetings and conferences. Creation of the investment case required due diligence of the available data, IP, development plan, budget and target product profile. A detailed landscape was then designed around the unmet clinical need, patient segments, treatment algorithm, current treatments, dominating players, comparable M&A/licensing deals and an estimate of the TPP’s market potential. Delivered material was then used by the client in 1-on-1s, pitch presentations and on stage at an international event.